We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.9B
AUM Growth
-$1.19B
Cap. Flow
-$1.27B
Cap. Flow %
-43.75%
Top 10 Hldgs %
34.83%
Holding
644
New
132
Increased
85
Reduced
129
Closed
248

Sector Composition

Rank Sector Weight
1 Financials 21.26%
2 Real Estate 14.1%
3 Healthcare 6.11%
4 Industrials 4.83%
5 Technology 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VC icon
276
Visteon
VC
$2.77B
$1.07M 0.04%
10,000
-56,000
-85% -$5.4M
PETX
277
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.07M 0.04%
60,000
+30,000
+100% +$374K
GLOG
278
CALL
DELISTED
GASLOG LTD
GLOG
$1.07M 0.04%
+52,500
New +$1.03M
ALNY icon
279
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.07M 0.04%
11,000
-3,000
-21% -$278K
ITB icon
280
iShares US Home Construction ETF
ITB
$2.41B
$1.03M 0.04%
+40,000
New +$976K
GNMK
281
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.02M 0.04%
75,000
-20,000
-21% -$224K
LII icon
282
Lennox International
LII
$18.8B
$998K 0.03%
+10,500
New +$933K
AFFX
283
DELISTED
Affymetrix Inc
AFFX
$987K 0.03%
100,000
ABCO
284
DELISTED
Advisory Board Co
ABCO
$980K 0.03%
20,000
+8,000
+67% +$377K
XLB icon
285
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
$972K 0.03%
+40,000
New +$967K
SPB icon
286
Spectrum Brands
SPB
$2.04B
$967K 0.03%
+10,105
New +$920K
QSR icon
287
CALL
Restaurant Brands International
QSR
$25.1B
$953K 0.03%
+24,400
New +$937K
ARRY
288
DELISTED
Array Biopharma Inc
ARRY
$946K 0.03%
200,000
-5,000
-2% -$19.8K
CSLT
289
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$936K 0.03%
80,000
+20,000
+33% +$239K
SBLK icon
290
CALL
Star Bulk Carriers
SBLK
$3.14B
$935K 0.03%
+28,520
New +$1.2M
GEVA
291
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$928K 0.03%
10,000
-5,000
-33% -$395K
LRMR icon
292
Larimar Therapeutics
LRMR
$416M
$925K 0.03%
2,500
-1,250
-33% -$322K
ALXN
293
DELISTED
Alexion Pharmaceuticals
ALXN
$925K 0.03%
5,000
INCY icon
294
PUT
Incyte
INCY
$23.5B
$914K 0.03%
+12,500
New +$817K
TRNX
295
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$893K 0.03%
35,000
-35,000
-50% -$892K
BRKR icon
296
Bruker
BRKR
$9.2B
$883K 0.03%
45,000
-5,000
-10% -$96.2K
KS
297
DELISTED
KapStone Paper and Pack Corp.
KS
$879K 0.03%
30,000
-20,000
-40% -$582K
RVTY icon
298
Revvity
RVTY
$12.3B
$875K 0.03%
20,000
-10,000
-33% -$431K
MZOR
299
DELISTED
Mazor Robotics Ltd.
MZOR
$869K 0.03%
70,000
OMER icon
300
Omeros
OMER
$709M
$867K 0.03%
35,000
-90,000
-72% -$1.64M

Similar funds

Weiss Multi-Strategy Advisers's Q4 2014 Portfolio in Review

As of Q4 2014, Weiss Multi-Strategy Advisers held 644 positions worth $2.9B, down 29% from $4.09B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $1.27B in Q4 2014, closing 248 positions and reducing 129 holdings. Its most notable exit was Coca-Cola Europacific Partners, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 12% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Capital One worth $45.4M.

  • Weiss Multi-Strategy Advisers's largest Q4 2014 buy was Capital One: 550,000 shares worth $45.4M.
  • Weiss Multi-Strategy Advisers added most to Prologis in Q4 2014, an estimated $36.2M increase.
  • Weiss Multi-Strategy Advisers's biggest Q4 2014 reduction was Synovus, cutting an estimated $27.8M.
  • Weiss Multi-Strategy Advisers fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $25.2M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 35% of its $2.9B portfolio in Q4 2014.
  • Weiss Multi-Strategy Advisers opened 132 new positions and closed 248 in Q4 2014.
  • Weiss Multi-Strategy Advisers's portfolio value fell 29% quarter-over-quarter to $2.9B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.